Spanish consensus on the use of natalizumab (Tysabri®) – 2011
Introduction: Natalizumab is very effective at reducing relapses and delaying disease progression in patients with relapsing-remitting multiple sclerosis (RRMS). However, treatment has also been associated with a risk of progressive multifocal leukoencephalopathy (PML). The aim of this article is to...
Збережено в:
| Автори: | , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier España
2012-09-01
|
| Серія: | Neurología (English Edition) |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2173580812001320 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|